BACKGROUND: The study investigated the discharge antithrombotic medication in patients with atrial fibrillation (AF) after major non-cardiac surgery and the impact on one-year outcomes. METHODS: A subgroup of 366 patients (mean age 75.9±10.5 years, women 42.3%, acute surgery 42.9%) undergoing major non-cardiac surgery and having any form of AF (30.6% of the total population enrolled in the PRAGUE-14 study) was followed for 1 year. RESULTS: Antithrombotics (interrupted due to surgery) were resumed until discharge in 51.8% of patients; less frequently in men (OR 0.6 (95% CI 0.95 to 0.35); p = 0.029), and in patients undergoing elective surgery (OR 0.6 (95% CI 0.91 to 0.33); p = 0.021). Dual antiplatelet therapy was resumed more often (91.7%) in comparison to aspirin monotherapy (57.3%; p = 0.047), and vitamin K antagonist (56.3%; p = 0.042). Patients with AF had significantly higher one-year mortality (22.1%) than patients without AF (14.1%, p = 0.001). The causes of death were: ischaemic events (32.6% of deaths), bleeding events (8.1%), others (N = 51; 59.3%, 20 of them died due to cancer). Non-reinstitution of aspirin until discharge was associated with higher one-year mortality (17.6% vs. 34.8%; p = 0.018). CONCLUSION: Preoperatively interrupted antithrombotics were re-administrated at discharge only in half of patients with AF, less likely in male patients and those undergoing elective surgery. The presence of AF was recognized as a predictor of one-year mortality, especially if aspirin therapy was not resumed until discharge. TRIAL REGISTRATION: ClinicalTrials.gov NCT01897220.

University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine Charles University Prague Prague Czech Republic

See more in PubMed

Kannel WB, Benjamin EJ. Final Draft Status of the Epidemiology of Atrial Fibrillation. Med Clin North Am. 2008; 92: 17 doi: 10.1016/j.mcna.2007.09.002 PubMed DOI PMC

Fuster V, Ryden LE, Cannom DS et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123:e269–e367. doi: 10.1161/CIR.0b013e318214876d PubMed DOI

Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2012; 163: 13–19 doi: 10.1016/j.ahj.2011.09.011 PubMed DOI

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, et al. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Am J Med. 2014; 127: 519–29 doi: 10.1016/j.amjmed.2013.12.022 PubMed DOI

Naughton C, Feneck RO. The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery. Int J Clin Pract 2007; 61: 768–776. doi: 10.1111/j.1742-1241.2007.01304.x PubMed DOI

Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S,et al.; Authors Task Force Members. 2014 ESC/ESA Guidelines on noncardiac surgery: cardiovascular assessment and management: The joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014; 35:2383–431 doi: 10.1093/eurheartj/ehu282 PubMed DOI

Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008; 372: 139–144 doi: 10.1016/S0140-6736(08)60878-8 PubMed DOI

Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major non-cardiac surgery. N Engl J Med. 2005; 353: 349–361. doi: 10.1056/NEJMoa041895 PubMed DOI

Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G,et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing non-cardiac surgery. JAMA. 2007; 297: 2481–2488. doi: 10.1001/jama.297.22.2481 PubMed DOI

Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major non-cardiac surgery. Circulation. 1999; 100: 1043–1049 PubMed

Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the medicare population. Anesth Analg. 1999; 89: 849–855. PubMed

Widimský P, Moťovská Z, Havlůj L, Ondráková M, Bartoška R, Bittner L, et al. Perioperative cardiovascular complications versus perioperative bleeding in consecutive patients with known cardiac disease undergoing non-cardiac surgery. Focus on antithrombotic medication. The PRAGUE-14 registry. Neth Heart J.2014; 22: 372–9 doi: 10.1007/s12471-014-0575-3 PubMed DOI PMC

Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Final results. Circulation 84(2), 527–539 (1991) PubMed

Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, et al. WARFASA Investigators. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012; 366: 1959–1967 doi: 10.1056/NEJMoa1114238 PubMed DOI

Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, et al. ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med.2012; 367: 1979–1987 doi: 10.1056/NEJMoa1210384 PubMed DOI

Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, et al. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 2014; 130: 1062–1071. doi: 10.1161/CIRCULATIONAHA.114.008828 PubMed DOI

van Diepen S, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing non-cardiac surgery: an analysis of 38 047 patients. Circulation. 2011; 124: 289–96. doi: 10.1161/CIRCULATIONAHA.110.011130 PubMed DOI

Gialdini G, Nearing K, Bhave PD, Bonuccelli U, Iadecola C, Healey JS, et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA. 2014; 312: 616–22. doi: 10.1001/jama.2014.9143 PubMed DOI PMC

McAlister FA, Jacka M, Graham M, Youngson E, Cembrowski G, Bagshaw SM, et al. The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing non-cardiac surgery: a VISION sub-study. J Thromb Haemost. 2015; 13: 1768–75. doi: 10.1111/jth.13110 PubMed DOI

See more in PubMed

ClinicalTrials.gov
NCT01897220